{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"55"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"18"}],"units":"Participants"}],"description":"Percentage of participants alive at 3 years post transplant","groups":[{"description":"Participants with the lowest tertile of measured busulfan Area under the curve (AUC); with a mean value of 5078 (full range 3933-5615) microM/min","id":"OG000","title":"Low Busulfan AUC Tertile (5078)"},{"description":"Participants with the lowest tertile of measured busulfan Area under the curve (AUC); with a mean value of 6372 (full range 5639-6965) microM/min","id":"OG001","title":"Intermediate Busulfan AUC Tertile (6372)"},{"description":"Participants with the lowest tertile of measured busulfan Area under the curve (AUC); with a mean value of 7605 (full range 7054-8863) microM/min","id":"OG002","title":"High Busulfan AUC Tertile (7605)"}],"paramType":"NUMBER","populationDescription":"Because AUC levels varied between the groups and the goal was to identify an actual achieved AUC-based dose, additional outcome analyses were undertaken by dividing patients into thirds according to the actual AUCs delivered rather than the original planned AUCs.","reportingStatus":"POSTED","timeFrame":"Three years post-transplant","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"percentage of participants"}